Aspire Biopharma Holdings (ASBP) Tax Rate (2024)
Aspire Biopharma Holdings' (ASBP) quarterly Tax Rate came in at 0.47% in Q3 2024.
Powered by 
Analysis
Aspire Biopharma Holdings (ASBP) Tax Rate (2024) Analysis & Trends
Aspire Biopharma Holdings (ASBP) has reported Tax Rate for 1 consecutive years, with 0.47% the latest figure, recorded in Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | 14.20% |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | -2.36% |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | 20.98% |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | 15.11% |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | -1.96% |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | -10.89% |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | 7.49% |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | 26.36% |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | 1.34% |
| 10 | Aspire Biopharma Holdings | 64.13 Mn | 51.96 Mn | -30,086.00 | - |